We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Updated: 5/12/2016
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Updated: 5/12/2016
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Click here to add this to my saved trials
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Updated: 5/17/2016
Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?
Status: Enrolling
Updated: 5/17/2016
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Updated: 5/17/2016
Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Induced Changes in Ventilatory Responsiveness and Altitude Exposure
Updated: 5/17/2016
Modulation of Oxygen Sensor Reactivity to Mimic Altitude Acclimatization
Status: Enrolling
Updated: 5/17/2016
Induced Changes in Ventilatory Responsiveness and Altitude Exposure
Updated: 5/17/2016
Modulation of Oxygen Sensor Reactivity to Mimic Altitude Acclimatization
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Updated: 5/17/2016
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Status: Enrolling
Updated: 5/17/2016
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Updated: 5/17/2016
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle
Updated: 5/18/2016
Effects of Low Level Carbon Monoxide Preconditioning on Human Mitochondrial Biogenesis in Aortic Valve Surgery Patients
Status: Enrolling
Updated: 5/18/2016
CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle
Updated: 5/18/2016
Effects of Low Level Carbon Monoxide Preconditioning on Human Mitochondrial Biogenesis in Aortic Valve Surgery Patients
Status: Enrolling
Updated: 5/18/2016
Click here to add this to my saved trials
Predictors of Anticoagulation Control on Warfarin Therapy
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Status: Enrolling
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Status: Enrolling
Updated: 5/19/2016
Click here to add this to my saved trials
Predictors of Anticoagulation Control on Warfarin Therapy
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Status: Enrolling
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Updated: 5/19/2016
Predictors of Anticoagulation Control on Warfarin Therapy
Status: Enrolling
Updated: 5/19/2016
Click here to add this to my saved trials
Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm
Updated: 5/19/2016
Automated Respiration Rate Evaluation to Improve Accuracy of the Early Warning Score Procedure Determined by the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm
Status: Enrolling
Updated: 5/19/2016
Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm
Updated: 5/19/2016
Automated Respiration Rate Evaluation to Improve Accuracy of the Early Warning Score Procedure Determined by the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm
Status: Enrolling
Updated: 5/19/2016
Click here to add this to my saved trials
Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients
Updated: 5/19/2016
Evaluation of Phosphodiesterase-5 Inhibition on Endothelial Function in Heart Transplant Recipients
Status: Enrolling
Updated: 5/19/2016
Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients
Updated: 5/19/2016
Evaluation of Phosphodiesterase-5 Inhibition on Endothelial Function in Heart Transplant Recipients
Status: Enrolling
Updated: 5/19/2016
Click here to add this to my saved trials
RNA Cloning and Visualization in Human Atherosclerosis
Updated: 5/23/2016
RNA Cloning and Visualization in Human Atherosclerosis
Status: Enrolling
Updated: 5/23/2016
RNA Cloning and Visualization in Human Atherosclerosis
Updated: 5/23/2016
RNA Cloning and Visualization in Human Atherosclerosis
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Ultrasound Elasticity Imaging of Venous Thrombi
Updated: 5/23/2016
Aging Venous Thrombi With Ultrasound Elasticity Imaging
Status: Enrolling
Updated: 5/23/2016
Ultrasound Elasticity Imaging of Venous Thrombi
Updated: 5/23/2016
Aging Venous Thrombi With Ultrasound Elasticity Imaging
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Updated: 5/24/2016
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Status: Enrolling
Updated: 5/24/2016
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Updated: 5/24/2016
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Status: Enrolling
Updated: 5/24/2016
Click here to add this to my saved trials
Palliative Care in Heart Failure
Updated: 5/25/2016
Palliative Care in Heart Failure (PAL-HF)
Status: Enrolling
Updated: 5/25/2016
Palliative Care in Heart Failure
Updated: 5/25/2016
Palliative Care in Heart Failure (PAL-HF)
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 5/31/2016
Updated: 5/31/2016
Click here to add this to my saved trials
Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization
Updated: 6/1/2016
A RCT to Reduce Cardiopulmonary Rehospitalization
Status: Enrolling
Updated: 6/1/2016
Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization
Updated: 6/1/2016
A RCT to Reduce Cardiopulmonary Rehospitalization
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Updated: 6/1/2016
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials